FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158290434> ?p ?o ?g. }

• W2158290434 endingPage "3267" @default.
• W2158290434 startingPage "3259" @default.
• W2158290434 abstract "To investigate the impact of newly identified chromosome 3p21 epigenetic tumor suppressors PBRM1, SETD2, and BAP1 on cancer-specific survival (CSS) of 609 patients with clear cell renal cell carcinoma (ccRCC) from 2 distinct cohorts.Select sequencing on 3p tumor suppressors of 188 patients who underwent resection of primary ccRCC at the Memorial Sloan-Kettering Cancer Center (MSKCC) was conducted to interrogate the genotype-phenotype associations. These findings were compared with analyses of the genomic and clinical dataset from our nonoverlapping The Cancer Genome Atlas (TCGA) cohort of 421 patients with primary ccRCC.3p21 tumor suppressors are frequently mutated in both the MSKCC (PBRM1, 30.3%; SETD2, 7.4%; BAP1, 6.4%) and the TCGA (PBRM1, 33.5%; SETD2, 11.6%; BAP1, 9.7%) cohorts. BAP1 mutations are associated with worse CSS in both cohorts [MSKCC, P = 0.002; HR 7.71; 95% confidence interval (CI)2.08-28.6; TCGA, P = 0.002; HR 2.21; 95% CI 1.35-3.63]. SETD2 are associated with worse CSS in the TCGA cohort (P = 0.036; HR 1.68; 95% CI 1.04-2.73). On the contrary, PBRM1 mutations, the second most common gene mutations of ccRCC, have no impact on CSS.The chromosome 3p21 locus harbors 3 frequently mutated ccRCC tumor suppressor genes. BAP1 and SETD2 mutations (6%-12%) are associated with worse CSS, suggesting their roles in disease progression. PBRM1 mutations (30%-34%) do not impact CSS, implicating its principal role in the tumor initiation. Future efforts should focus on therapeutic interventions and further clinical, pathologic, and molecular interrogation of this novel class of tumor suppressors." @default.
• W2158290434 created "2016-06-24" @default.
• W2158290434 creator A5003119579 @default.
• W2158290434 creator A5008166270 @default.
• W2158290434 creator A5010536553 @default.
• W2158290434 creator A5019708503 @default.
• W2158290434 creator A5021734597 @default.
• W2158290434 creator A5028587910 @default.
• W2158290434 creator A5030709443 @default.
• W2158290434 creator A5033125884 @default.
• W2158290434 creator A5051277222 @default.
• W2158290434 creator A5053307625 @default.
• W2158290434 creator A5059063118 @default.
• W2158290434 creator A5060705907 @default.
• W2158290434 creator A5061030806 @default.
• W2158290434 creator A5086570651 @default.
• W2158290434 creator A5089094298 @default.
• W2158290434 creator A5091859782 @default.
• W2158290434 date "2013-06-13" @default.
• W2158290434 modified "2023-10-17" @default.
• W2158290434 title "Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators <i>BAP1</i> and <i>SETD2</i>: A Report by MSKCC and the KIRC TCGA Research Network" @default.
• W2158290434 cites W1977845140 @default.
• W2158290434 cites W1981662202 @default.
• W2158290434 cites W1988303870 @default.
• W2158290434 cites W1992142098 @default.
• W2158290434 cites W2007265317 @default.
• W2158290434 cites W2019756490 @default.
• W2158290434 cites W2024064023 @default.
• W2158290434 cites W2038981426 @default.
• W2158290434 cites W2041806580 @default.
• W2158290434 cites W2057802075 @default.
• W2158290434 cites W2060605982 @default.
• W2158290434 cites W2072257321 @default.
• W2158290434 cites W2079212177 @default.
• W2158290434 cites W2092892924 @default.
• W2158290434 cites W2095698093 @default.
• W2158290434 cites W2103313018 @default.
• W2158290434 cites W2115494288 @default.
• W2158290434 cites W2121659103 @default.
• W2158290434 cites W2121827874 @default.
• W2158290434 cites W2122769974 @default.
• W2158290434 cites W2126675803 @default.
• W2158290434 cites W2152874907 @default.
• W2158290434 cites W2165948908 @default.
• W2158290434 cites W2172050766 @default.
• W2158290434 cites W2602373161 @default.
• W2158290434 cites W4238906713 @default.
• W2158290434 doi "https://doi.org/10.1158/1078-0432.ccr-12-3886" @default.
• W2158290434 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3708609" @default.
• W2158290434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23620406" @default.
• W2158290434 hasPublicationYear "2013" @default.
• W2158290434 type Work @default.
• W2158290434 sameAs 2158290434 @default.
• W2158290434 citedByCount "281" @default.
• W2158290434 countsByYear W21582904342013 @default.
• W2158290434 countsByYear W21582904342014 @default.
• W2158290434 countsByYear W21582904342015 @default.
• W2158290434 countsByYear W21582904342016 @default.
• W2158290434 countsByYear W21582904342017 @default.
• W2158290434 countsByYear W21582904342018 @default.
• W2158290434 countsByYear W21582904342019 @default.
• W2158290434 countsByYear W21582904342020 @default.
• W2158290434 countsByYear W21582904342021 @default.
• W2158290434 countsByYear W21582904342022 @default.
• W2158290434 countsByYear W21582904342023 @default.
• W2158290434 crossrefType "journal-article" @default.
• W2158290434 hasAuthorship W2158290434A5003119579 @default.
• W2158290434 hasAuthorship W2158290434A5008166270 @default.
• W2158290434 hasAuthorship W2158290434A5010536553 @default.
• W2158290434 hasAuthorship W2158290434A5019708503 @default.
• W2158290434 hasAuthorship W2158290434A5021734597 @default.
• W2158290434 hasAuthorship W2158290434A5028587910 @default.
• W2158290434 hasAuthorship W2158290434A5030709443 @default.
• W2158290434 hasAuthorship W2158290434A5033125884 @default.
• W2158290434 hasAuthorship W2158290434A5051277222 @default.
• W2158290434 hasAuthorship W2158290434A5053307625 @default.
• W2158290434 hasAuthorship W2158290434A5059063118 @default.
• W2158290434 hasAuthorship W2158290434A5060705907 @default.
• W2158290434 hasAuthorship W2158290434A5061030806 @default.
• W2158290434 hasAuthorship W2158290434A5086570651 @default.
• W2158290434 hasAuthorship W2158290434A5089094298 @default.
• W2158290434 hasAuthorship W2158290434A5091859782 @default.
• W2158290434 hasBestOaLocation W21582904341 @default.
• W2158290434 hasConcept C104317684 @default.
• W2158290434 hasConcept C121608353 @default.
• W2158290434 hasConcept C126322002 @default.
• W2158290434 hasConcept C143998085 @default.
• W2158290434 hasConcept C2777472916 @default.
• W2158290434 hasConcept C2781278892 @default.
• W2158290434 hasConcept C37846818 @default.
• W2158290434 hasConcept C41091548 @default.
• W2158290434 hasConcept C502942594 @default.
• W2158290434 hasConcept C54355233 @default.
• W2158290434 hasConcept C71924100 @default.
• W2158290434 hasConcept C86803240 @default.
• W2158290434 hasConceptScore W2158290434C104317684 @default.
• W2158290434 hasConceptScore W2158290434C121608353 @default.
• W2158290434 hasConceptScore W2158290434C126322002 @default.

• next